A relatively new cancer drug – Avastin (bevacizumab) – currently used in treatment of lung and colorectal cancers, has recently been found to slow the growth of the most common and deadly form of brain cancer -gliomas.
Such is the finding of a Duke University Medical Center pilot study in which the researchers tested the effectiveness of Avastin in conjunction with a standard chemotherapy agent in patients with recurrent cancerous brain tumors called gliomas.
…found that the two drugs together halted tumor growth up to twice as long as comparative therapies.
Though gliomas remain incurable in nearly all cases, the combined drug therapy …read more

Gliomas are the scariest group of brain tumors, the most common type of which is the most aggressive.
Malignant gliomas are least affected by chemotherapy and radiation. Patients only survive a year after diagnosis.
Shedding light into this seeming hopeless, fatal condition, Lund University (Sweden) research suggests that stem cells from the brain can be developed to treat gliomas.
Using the following theories:

Neural stem cells have been shown to have the ability to recognize signals from tumor cells in the brain and migrate there.
If stem cells are injected into a part of the brain in laboratory animals with a glioma in another part …read more